Article

Effect of implantation site and injury condition on host response to human-derived fascia lata ECM in a rat model.

Department of Biomedical Engineering, Orthopaedic Research Center, Lerner Research Institute, ND20, Cleveland Clinic, Cleveland, Ohio, USA.
Journal of Orthopaedic Research (impact factor: 2.81). 08/2011; 30(3):461-7. DOI:10.1002/jor.21529 pp.461-7
Source: PubMed

ABSTRACT The host response and remodeling of ECM scaffolds are believed to be critical determinants of success or failure in repair or reconstructive procedures. Host response has been investigated in subcutaneous or abdominal wall implantation models. The extent to which evaluation of the host response to ECM intended for tendon or ligament repair should be performed in an orthotopic site is not known. This study compared the host response to human-derived fascia lata ECM among various implantation sites in the rat model. Results showed that a xenograft in the rat shoulder does not exhibit a different host response at 7 days from xenograft in the body wall, suggesting that either site may be appropriate to study the early host response to biologic grafts as well as the effect of various treatments aimed to modify the early host response. By 28 days, a xenograft in the rat shoulder does elicit a unique host response from that seen in the body wall. Therefore, it may be more appropriate to use an orthotopic shoulder model for investigating the long-term host response and remodeling of biologic grafts to be used for rotator cuff repair.

0 0
 · 
0 Bookmarks
 · 
25 Views
  • Article: Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    [show abstract] [hide abstract]
    ABSTRACT: The EORTC QLQ-C30 health-related quality of life (HRQoL) questionnaire was developed for use in clinical cancer trials. It has also been applied in studies of patients with chronic nonmalignant pain in spite of nondocumented validity. Validation of the EORTC QLQ-C30 in this patient population and comparison with the traditional first choice HRQoL instrument in chronic nonmalignant pain, the SF-36, are, therefore, required. Two hundred eighty-six patients admitted to the tertiary multidisciplinary pain center at St. Olavs University Hospital in Trondheim, Norway, completed both the EORTC QLQ-C30 and the SF-36 at admittance. Correlations between EORTC QLQ-C30 and SF-36 measures of the same concept were between 0.70 and 0.81 for all five domains covered by both instruments. Internal consistency was below 0.70 for the EORTC QLQ-C30 scales physical functioning (0.57), pain (0.68), role functioning (0.43), cognitive functioning (0.66), and nausea/vomiting (0.53), as well as the SF-36 scale role emotional functioning (0.66). Large floor or ceiling effects were seen for several EORTC QLQ-C30 scales. While SF-36 addresses no other symptoms than pain and fatigue, the EORTC QLQ-C30 also includes sleep, financial difficulties, nausea/vomiting, dyspnea, appetite loss, constipation, and diarrhea. Even though some EORTC QLQ-C30 scales have unsatisfactory internal consistency, EORTC QLQ-C30, similar to SF-36, has overall acceptable psychometric properties. The EORTC QLQ-C30 is a valid alternative to the SF-36 when a broader assessment of symptoms is desired.
    Journal of Pain and Symptom Management 01/2008; 34(6):657-65. · 2.50 Impact Factor

Keywords

abdominal wall implantation models
 
appropriate
 
biologic grafts
 
body wall
 
different host response
 
ECM scaffolds
 
host response
 
human-derived fascia lata ECM
 
long-term host response
 
orthotopic shoulder model
 
orthotopic site
 
rat shoulder
 
reconstructive procedures
 
rotator cuff
 
subcutaneous
 
tendon
 
unique host response
 
various implantation sites
 
various treatments
 
xenograft
 

Diane R Leigh